| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.024 | 0.9 |